Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 84.56% is in line with its 5-year average of 83.15%, around the middle of its 5-year range (78.87%–89.76%).
0.93% below its 12-month average of 85.36%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 80.22%.
GROSS MARGIN
84.56%
GROSS MARGIN AVG TTM
85.36%
GROSS MARGIN AVG 3Y
84.81%
GROSS MARGIN AVG 5Y
83.15%
GROSS MARGIN AVG 10Y
83.11%
GROSS MARGIN AVG 15Y
80.08%
GROSS MARGIN AVG 20Y
79.33%
CURRENT VS TTM AVG
-0.93%
CURRENT VS 3Y AVG
-0.29%
CURRENT VS 5Y AVG
+1.70%
CURRENT VS 10Y AVG
+1.75%
CURRENT VS 15Y AVG
+5.60%
CURRENT VS 20Y AVG
+6.60%
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
+97.06%
vs the sector median at left
Market Cap
$7.25B
Gross Margin
98.16%
TTM Avg
98.36%
3Y Avg
98.29%
5Y Avg
98.36%
Market Cap
$6.55B
Gross Margin
73.84%
TTM Avg
76.65%
3Y Avg
78.21%
5Y Avg
76.94%
Market Cap
$6.53B
Gross Margin
60.14%
TTM Avg
62.77%
3Y Avg
60.62%
5Y Avg
54.58%
Market Cap
$6.52B
Gross Margin
39.32%
TTM Avg
37.08%
3Y Avg
36.51%
5Y Avg
35.71%
Market Cap
$7.62B
Gross Margin
84.52%
TTM Avg
78.41%
3Y Avg
74.39%
5Y Avg
74.39%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alkermes plc (ALKS) | $7.04B | 84.56% | 85.36% | 84.81% | 83.15% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.25B | 98.16% | 98.36% | 98.29% | 98.36% |
| Immunovant, Inc. (IMVT)vs › | $6.75B | 0.00% | 0.00% | 0.00% | 0.00% |
| GRAIL Inc. (GRAL)vs › | $6.74B | -42.52% | -52.32% | -104.24% | -183.56% |
| Chemed Corporation (CHE)vs › | $6.68B | 30.44% | 32.55% | 34.06% | 34.32% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.55B | 73.84% | 76.65% | 78.21% | 76.94% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | 60.14% | 62.77% | 60.62% | 54.58% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 39.32% | 37.08% | 36.51% | 35.71% |
| Hinge Health, Inc. (HNGE)vs › | $7.62B | 84.52% | 78.41% | 74.39% | 74.39% |
| HealthEquity, Inc. (HQY)vs › | $7.63B | 75.21% | 63.63% | 56.54% | 52.91% |
Gross Margin
84.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 80.22% |
| 2026-03-31 | 84.33% |
| 2025-12-31 | 87.98% |
| 2025-09-30 | 86.91% |
| 2025-06-30 | 87.34% |
| 2025-03-31 | 83.95% |
| 2024-12-31 | 85.55% |
| 2024-09-30 | 83.31% |
| 2024-06-30 | 84.60% |
| 2024-03-31 | 83.26% |
| 2023-12-31 | 81.43% |
| 2023-09-30 | 83.86% |
| 2023-06-30 | 89.76% |
| 2023-03-31 | 79.78% |
| 2022-12-31 | 82.29% |
| 2022-09-30 | 79.94% |
| 2022-06-30 | 78.87% |
| 2022-03-31 | 80.20% |
| 2021-12-31 | 83.46% |
| 2021-09-30 | 83.15% |
| 2021-06-30 | 82.51% |
| 2021-03-31 | 83.69% |
| 2020-12-31 | 84.67% |
| 2020-09-30 | 83.73% |
| 2020-06-30 | 81.80% |
| 2020-03-31 | 80.83% |
| 2019-12-31 | 88.74% |
| 2019-09-30 | 83.42% |
| 2019-06-30 | 83.48% |
| 2019-03-31 | 79.67% |
| 2018-12-31 | 84.44% |
| 2018-09-30 | 84.15% |
| 2018-06-30 | 85.75% |
| 2018-03-31 | 80.25% |
| 2017-12-31 | 86.02% |
| 2017-09-30 | 83.41% |
| 2017-06-30 | 81.82% |
| 2017-03-31 | 78.93% |
| 2016-12-31 | 83.63% |
| 2016-09-30 | 80.33% |
| 2016-06-30 | 82.58% |
| 2016-03-31 | 82.32% |
| 2015-12-31 | 78.67% |
| 2015-09-30 | 77.85% |
| 2015-06-30 | 79.90% |
| 2015-03-31 | 75.20% |
| 2014-12-31 | 73.53% |
| 2014-09-30 | 70.41% |
| 2014-06-30 | 71.78% |
| 2014-03-31 | 70.17% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 67.51% |
| 2013-06-30 | 66.82% |
| 2013-03-31 | 70.63% |
| 2012-12-31 | 71.37% |
| 2012-09-30 | 66.53% |
| 2012-06-30 | 72.37% |
| 2012-03-31 | 60.85% |
| 2011-12-31 | 65.97% |
| 2011-09-30 | 75.65% |
| 2011-06-30 | 73.79% |
| 2011-03-31 | 75.07% |
| 2010-12-31 | 70.76% |
| 2010-09-30 | 71.75% |
| 2010-06-30 | 70.04% |
| 2010-03-31 | 69.83% |
| 2009-12-31 | 77.19% |
| 2009-09-30 | 68.66% |
| 2009-06-30 | 73.33% |
| 2009-03-31 | 73.85% |
| 2008-12-31 | 96.44% |
| 2008-09-30 | 74.49% |
| 2008-06-30 | 82.11% |
| 2008-03-31 | 77.86% |
| 2007-12-31 | 85.23% |
| 2007-09-30 | 84.27% |
| 2007-06-30 | 85.28% |
| 2007-03-31 | 82.94% |
| 2006-12-31 | 79.19% |
| 2006-09-30 | 80.67% |
| 2006-06-30 | 81.88% |
| 2006-03-31 | 84.09% |
| 2005-12-31 | 85.33% |
| 2005-09-30 | 90.66% |
| 2005-06-30 | 81.81% |
| 2005-03-31 | 81.45% |
| 2004-12-31 | 79.10% |
| 2004-09-30 | 86.75% |
| 2004-06-30 | 54.32% |
| 2004-03-31 | 51.25% |
| 2003-12-31 | 63.73% |
| 2003-09-30 | 38.70% |
| 2003-06-30 | 40.47% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
